4//SEC Filing
KOBLAN KENNETH S 4
Accession 0001325812-10-000044
CIK 0001178670other
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 4:52 PM ET
Size
5.7 KB
Accession
0001325812-10-000044
Insider Transaction Report
Form 4
KOBLAN KENNETH S
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2010-12-08+10,000→ 10,000 totalExercise: $9.14Exp: 2020-12-08→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.
Documents
Issuer
ALNYLAM PHARMACEUTICALS, INC.
CIK 0001178670
Entity typeother
Related Parties
1- filerCIK 0001506914
Filing Metadata
- Form type
- 4
- Filed
- Dec 9, 7:00 PM ET
- Accepted
- Dec 10, 4:52 PM ET
- Size
- 5.7 KB